PMC:7499623 / 8796-9806
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 610-615 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T5 | 610-615 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T38 | 0-24 | Disease | denotes | Coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T39 | 102-110 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T40 | 397-405 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T41 | 659-667 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T52 | 498-499 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T53 | 559-560 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T54 | 610-615 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T55 | 634-636 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T56 | 657-658 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T57 | 677-681 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T58 | 770-771 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T59 | 838-839 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T60 | 849-853 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T61 | 882-883 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T62 | 893-897 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
141 | 0-24 | Disease | denotes | Coronavirus disease 2019 | MESH:C000657245 |
144 | 70-78 | Species | denotes | patients | Tax:9606 |
145 | 102-110 | Disease | denotes | COVID-19 | MESH:C000657245 |
149 | 261-269 | Species | denotes | patients | Tax:9606 |
150 | 280-288 | Species | denotes | patients | Tax:9606 |
151 | 315-323 | Species | denotes | patients | Tax:9606 |
154 | 375-383 | Species | denotes | patients | Tax:9606 |
155 | 397-405 | Disease | denotes | COVID-19 | MESH:C000657245 |
158 | 723-730 | Species | denotes | patient | Tax:9606 |
159 | 659-667 | Disease | denotes | COVID-19 | MESH:C000657245 |
161 | 966-974 | Species | denotes | patients | Tax:9606 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T87 | 0-34 | Sentence | denotes | Coronavirus disease 2019 screening |
T88 | 35-46 | Sentence | denotes | Question 9: |
T89 | 47-166 | Sentence | denotes | What thoracic surgical patients are being screened for COVID-19 in your department? (Answer rate 405/409, 99%) (Fig. 2) |
T90 | 167-335 | Sentence | denotes | The answers were variable with the same proportion of respondents reporting screening for all patients (25%), in-patients only (24%) or symptomatic patients only (23%). |
T91 | 336-348 | Sentence | denotes | Question 10: |
T92 | 349-463 | Sentence | denotes | How are thoracic surgical patients screened for COVID-19 in your department? (Answer rate 400/409, 97.7%) (Fig. 2) |
T93 | 464-624 | Sentence | denotes | The majority (54%) responded that a nasopharyngeal swab alone was used for screening; 30% used a combination of swab and computed tomography (CT) chest imaging. |
T94 | 625-637 | Sentence | denotes | Question 11: |
T95 | 638-769 | Sentence | denotes | Does the result of a COVID-19 positive test influence the surgical treatment of your patient? (Answer rate 398/409, 97.3%) (Fig. 2) |
T96 | 770-861 | Sentence | denotes | A total of 7% of respondents would proceed to surgery regardless of a positive test result. |
T97 | 862-1010 | Sentence | denotes | The majority stated a positive test result would be an indication to postpone surgery by 2 weeks in all patients (59%) or those with symptoms (19%). |
testtesttest
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T6 | 610-615 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |